U.S. Nucleic Acid Amplification Testing Market Size & Outlook

Name: U.S. Nucleic Acid Amplification Testing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The nucleic acid amplification testing market in the United States is expected to reach a projected revenue of US$ 7,613.7 million by 2033. A compound annual growth rate of 8.47% is expected of the United States nucleic acid amplification testing market from 2026 to 2033.

Clinical Diagnostics
- In Vitro Diagnostics
  - nucleic acid amplification testing naat market

U.S. nucleic acid amplification testing naat application outlook (Revenue, USD million, 2021-2033)
- Infectious Disease Testing
  - COVID-19 Testing
  - Mosquito Borne Disease Testing
  - Influenza Testing
  - Sexually Transmitted Infection Testing
  - Hepatitis Testing
  - Tuberculosis Testing
  - Others
- Oncology Testing
- Genetic & Mitochondrial Disease Testing
- Others
U.S. nucleic acid amplification testing naat type outlook (Revenue, USD million, 2021-2033)
- Polymerase Chain Reaction (PCR) Tests
- Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
- Ligase Chain Reaction (LCR) Tests
U.S. nucleic acid amplification testing naat end use outlook (Revenue, USD million, 2021-2033)
- Hospitals
- Central and reference laboratories
- Others

U.S. Nucleic Acid Amplification Testing Market Size & Outlook

Data Tree

Sign up - it's easy, and free!